Basic and clinical investigation of the mechanism in the aldosterone regulation by the sympathetic system
交感神经系统调节醛固酮机制的基础与临床研究
基本信息
- 批准号:22780284
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Young Scientists (B)
- 财政年份:2010
- 资助国家:日本
- 起止时间:2010 至 2011
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Our objectivewas to investigate the effectsof doxycycline, a matrix metalloproteinase(MMP) inhibitor(MMPi) on ss-agonist-induced myocardial fibrosis and MMP expression. Rats were divided into 3groups : control, Isoproterenol(ISO), and Isoproterenolwith doxycycline(ISO+DOX). Compared to the control, ISO induced the myocardial hypertrophyand cardiacfibrosis, but were attenuated by co-treatment with DOX. MMP-2 activity alsoincreased in the ISO treatment, but decreased by co-treatment with DOX. Similarly, immunoblotting showedsignificant increaseinMMP-2levelin the ISO, and decreased levels in the DOX co-treatment. Ourresults suggest that the enhanced expression of MMP-2plays a prominent role inpromoting myocardial fibrosis inβ-agonist signaling pathway, and that MMP-inhibiting compoundsmay attenuate myocardial fibrosis.
我们的目的是研究多西环素,一种基质金属蛋白酶(MMP)抑制剂(MMPi)对β受体激动剂诱导的心肌纤维化和MMP表达的影响。将大鼠分为对照组、异丙肾上腺素组(ISO组)和异丙肾上腺素+多西环素组(ISO+DOX组)。与对照组相比,ISO可引起心肌肥厚和心肌纤维化,DOX可减轻ISO的心肌肥厚和心肌纤维化。MMP-2活性在ISO处理中也增加,但在DOX的共同处理中降低。同样,免疫印迹显示ISO组MMP-2水平显著升高,DOX联合治疗组MMP-2水平降低。结果提示,MMP-2的表达增强在β-激动剂信号通路中起着促进心肌纤维化的重要作用,MMP抑制剂可减轻心肌纤维化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
心筋線維芽細胞における交感神経受容体を介したアルドステロン分泌機序の解明
阐明心脏成纤维细胞交感神经受体介导的醛固酮分泌机制
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:藤栄大輔;堀泰智
- 通讯作者:堀泰智
Spironolactone Decreases Isoproterenol-Induced Ventricular Fibrosis and Matrix Metalloproteinase-2 in Rats
- DOI:10.1248/bpb.34.61
- 发表时间:2011-01-01
- 期刊:
- 影响因子:2
- 作者:Hori, Yasutomo;Yoshioka, Kazuki;Higuchi, Sei-ichi
- 通讯作者:Higuchi, Sei-ichi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORI Yasutomo其他文献
HORI Yasutomo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORI Yasutomo', 18)}}的其他基金
Investigation of the mechanism in the aldosterone regulation through the beta-adrenergic receptor
通过β-肾上腺素受体调节醛固酮的机制研究
- 批准号:
24580463 - 财政年份:2012
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the fibrogenic mechanism mediated by MMP activity: basic study to an anti-fibrotic therapy.
MMP 活性介导的纤维形成机制分析:抗纤维化治疗的基础研究。
- 批准号:
20780227 - 财政年份:2008
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
相似海外基金
脳卒中・心臓病のCircular Healthcare Systemに関する研究
脑卒中、心脏病循环医疗体系研究
- 批准号:
23K24450 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
BIONIC HEARTS: Bio-IONomerIC polymers for the regenerative therapy of HEART disease and Stroke
仿生心脏:用于心脏病和中风再生治疗的生物离聚物聚合物
- 批准号:
EP/Y004434/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Operating Grants
Getting to the Heart of Domestic Abuse: Identifying the molecular mechanisms of heart disease in association with physical and psychological stress
深入了解家庭暴力的核心:确定心脏病与身体和心理压力相关的分子机制
- 批准号:
486978 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Operating Grants
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Determining the genetic and social determinants of heart failure and mortality in patients with congenital heart disease
确定先天性心脏病患者心力衰竭和死亡率的遗传和社会决定因素
- 批准号:
10735690 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Extracellular drivers of myocyte stiffening in diastolic heart disease
舒张性心脏病心肌细胞僵硬的细胞外驱动因素
- 批准号:
10936206 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Using Administrative Health Data to Understand Readmissions after Early Discharge following Transcatheter Congenital Heart Disease Interventions in Canada
使用管理健康数据了解加拿大经导管先天性心脏病干预后提前出院后的再入院情况
- 批准号:
488422 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Operating Grants
Sex Differences in Psychosocial and Neurocognitive Outcomes in Adults with Moderate to Complex Congenital Heart Disease
患有中度至复杂先天性心脏病的成人心理社会和神经认知结果的性别差异
- 批准号:
10825104 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别: